These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11070938)

  • 1. [Sézary syndrome showing a stable clinical course for more than four years after oral administration of etoposide and methotrexate].
    Hirayama Y; Nagai T; Ohta H; Koyama R; Matsunaga T; Sakamaki S; Niitsu Y
    Rinsho Ketsueki; 2000 Sep; 41(9):750-4. PubMed ID: 11070938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The Sézary syndrome].
    Ferreira F; Correia TM; Callabro L; Andrade J
    Acta Med Port; 1998 Dec; 11(12):1135-9. PubMed ID: 10192992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Extracorporeal photopheresis in the therapy of Sézary syndrome].
    Marschalkó M; Knobler R; Soós G; Berecz M; Pálóczy K; Rácz I
    Orv Hetil; 1993 Jun; 134(23):1253-7. PubMed ID: 8332344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral bexarotene in a therapy-resistant Sézary syndrome patient: observations on Sézary cell compartmentalization.
    el-Azhary RA; Bouwhuis SA
    Int J Dermatol; 2005 Jan; 44(1):25-8. PubMed ID: 15663654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Complication of topoisomerase II inhibitor-related acute promyelocytic leukemia with t(1;10) (q21;q26) in a patient with Sézary syndrome].
    Miyoshi N; Noda M
    Rinsho Ketsueki; 2006 May; 47(5):399-401. PubMed ID: 16784098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Successful combination chemotherapy including deoxycoformycin in a case of cutaneous T cell lymphoma].
    Kodama K; Yamada T; Kawakami K; Yasui K; Nomura T; Yamaoka M; Matsuo T
    Rinsho Ketsueki; 1996 Jan; 37(1):65-71. PubMed ID: 8683870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracorporeal photopheresis for the treatment of Sézary syndrome using a novel treatment protocol.
    Arulogun S; Prince HM; Gambell P; Lade S; Ryan G; Eaton E; McCormack C
    J Am Acad Dermatol; 2008 Oct; 59(4):589-95. PubMed ID: 18656282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurolymphomatosis associated with Sézary syndrome.
    Bezier M; Reguiaï Z; Delaby P; Laroche L; Saïd G; Bernard P; Grange F
    Arch Dermatol; 2009 Mar; 145(3):294-6. PubMed ID: 19289760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Small cell lung cancer with Sézary syndrome].
    Nakanishi M; Kubota Y; Hara H; Ueda M; Arimoto T; Iwasaki Y
    Nihon Kokyuki Gakkai Zasshi; 2009 Dec; 47(12):1135-40. PubMed ID: 20058693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sézary syndrome without erythroderma.
    Henn A; Michel L; Fite C; Deschamps L; Ortonne N; Ingen-Housz-Oro S; Marinho E; Beylot-Barry M; Bagot M; Laroche L; Crickx B; Maubec E
    J Am Acad Dermatol; 2015 Jun; 72(6):1003-9.e1. PubMed ID: 25981000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of late-stage Sézary syndrome with 2-Chlorodeoxyadenosine.
    Bouwhuis SA; el-Azhary RA; McEvoy MT; Gibson LE; Habermann TM; Witzig TE; Pittelkow MR
    Int J Dermatol; 2002 Jun; 41(6):352-6. PubMed ID: 12100691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sezary syndrome presenting with leonine facies and treated with low-dose subcutaneous alemtuzumab.
    Oliveira A; Lobo I; Alves R; Lima M; Selores M
    Dermatol Online J; 2011 Nov; 17(11):6. PubMed ID: 22136862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A woman with Sezary syndrome developed HTLV-1-associated myeloneuropathy. The reported case supports the theory of etiological connection].
    Roupe G
    Lakartidningen; 2003 Jul; 100(30-31):2441-2. PubMed ID: 12914139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors.
    Revesz D; Chelghoum Y; Le QH; Elhamri M; Michallet M; Thomas X
    Ann Hematol; 2003 Nov; 82(11):684-90. PubMed ID: 12928754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of apoptosis of Sézary cells in the circulation following oral bexarotene therapy.
    Brennand S; Sutton VR; Biagi J; Trapani JA; Westerman D; McCormack CJ; Seymour JF; Kennedy G; Prince HM
    Br J Dermatol; 2005 Jun; 152(6):1199-205. PubMed ID: 15948982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atopic dermatitis-like pre-Sézary syndrome: role of immunosuppression.
    Sokołowska-Wojdyło M; Barańska-Rybak W; Cegielska A; Trzeciak M; Lugowska-Umer H; Gniadecki R
    Acta Derm Venereol; 2011 Sep; 91(5):574-7. PubMed ID: 21681350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained remission of Sézary syndrome.
    Bouwhuis SA; McEvoy MT; Davis MD
    Eur J Dermatol; 2002; 12(3):287-90. PubMed ID: 11978575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Sézary syndrome with bexarotene after IFNalpha and methotrexate failure.
    Bagot M
    Dermatol Clin; 2008 Jan; 26 Suppl 1():27-9. PubMed ID: 18405184
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haematodermic CD4+CD56+ neoplasm: complete remission after methotrexate-asparaginase treatment.
    Fontaine J; Thomas L; Balme B; Ronger-Savle S; Traullé C; Petrella T; Dalle S
    Clin Exp Dermatol; 2009 Jul; 34(5):e43-5. PubMed ID: 19508475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.